熱門資訊> 正文
iBio公开募股定价5000万美元
2025-08-19 20:21
- iBio, Inc.(IBIO) 0
- 纳比特(NA) 0
- 盛大科技(SDA) 0
- iBio (NASDAQ:IBIO) announced a $50M underwritten public offering.
- The offering includes 71.54M pre-funded warrants and Series G and H warrants to purchase a total of 71.54M shares.
- Each unit (1 pre-funded warrant + 1 Series G warrant + 1 Series H warrant) is priced at $0.699. Series G and H warrants have an exercise price of $0.70 per share and various expiration terms tied to trial milestones.
- The offering is expected to close on or around August 22, 2025.
- Proceeds will fund development of cardiometabolic candidates IBIO-610 and IBIO-600, other preclinical assets, and general corporate purposes.
- Additional $50M could be raised if all Series G and H warrants are exercised in cash.
- IBIO shares down 3% premarket on Tuesday.
- Source: Press release
More on iBio
- iBio drops on proposed public offering
- Seeking Alpha’s Quant Rating on iBio
- Historical earnings data for iBio
- Financial information for iBio
推薦文章
萬億南向「活水」瘋狂搶籌！重倉阿里巴巴逾1200億港元，如何抄「聰明錢」的作業？
「AI暴力美學」！一文盤點：「甲骨文之夜」留下的那些驚人數字
新股申購 | 「新葯開發公司」勁方醫藥-B今起招股！一手入場費4119.13港元
華盛早報 | 市值一夜暴增1.73萬億，新晉世界首富誕生；降息預期拉滿，特朗普怒噴鮑威爾
降息預期壓倒經濟隱憂！調查顯示：美股今年有望強勢收官
9月11日外盤頭條：特朗普誓要罷免美聯儲理事庫克 甲骨文暴漲36% 創始人盤中登頂首富 美勞工部預審查統計局
美股機會日報 | 美國8月PPI低於預期！三大股指期貨短線拉昇；甲骨文盤前飆升超30%
美聯儲下周要降息50基點？這八大降息交易方向值得關注！黃金已搶跑10%
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
